Results 321 to 330 of about 1,463,832 (396)
Recent developments in diagnosis and treatment of nasopharyngeal carcinoma.
Tai-Fu Liu
openalex
Nasopharyngeal carcinoma in childhood and adolescence
Pedro Zubizarreta+8 more
openalex +1 more source
Potential Active Compounds of Ganoderma lucidum and Their Anticancer Effects: A Comprehensive Review
This paper systematically discusses various active compounds within Ganoderma lucidum and their application in the treatment of tumor diseases. ABSTRACT The incidence and mortality rates of cancer patients continue to rise. Although many physical and chemical therapies, such as targeted tumor treatments, are effective against cancer, they are often ...
Yuan Liu+4 more
wiley +1 more source
The Efficacy of Hellebrigenin Against Nasopharyngeal Carcinoma Cells: The Molecular and Bioinformatic Analysis. [PDF]
Ho HY+6 more
europepmc +1 more source
ABSTRACT Background and Purpose Full‐dose postoperative external beam radiation therapy (EBRT)/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine the long‐term results of adjuvant high‐dose rate (HDR) brachytherapy ± intermediate‐dose postoperative external beam ...
Alejandro García‐Consuegra+10 more
wiley +1 more source
Prognosis of nasopharyngeal carcinoma in children and adolescents: a population-based analysis. [PDF]
Shi Y, Wu Y, He J, Ling Y, Liu W.
europepmc +1 more source
Vision Changes After Head and Neck Cancer Treatment
ABSTRACT Background Literature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients. Methods The study used a cross‐sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI‐VFQ) and an Ocular Symptom Scale ...
Hsiao‐Lan Wang+7 more
wiley +1 more source
Loss of CDS1 impairs the tumorigenic characteristics of nasopharyngeal carcinoma by modulating lipid metabolism. [PDF]
Wang Y+15 more
europepmc +1 more source
ABSTRACT Background The efficacy of anti‐PD‐1 and EGFR therapies for head and neck squamous cell carcinoma (HNSCC) can be predicted using various markers; however, the stability of these markers remains unclear. Methods In this retrospective study, laboratory findings and tissue expression of PD‐L1, PD‐L2, and EGFR were analyzed in 79 paired naive and ...
Ryosuke Sato+13 more
wiley +1 more source